Titan Pharmaceuticals

Results: 7



#Item
1TITAN	PHARMACEUTICALS	  CORPORATE	PRESENTATION	Ÿ	SUNIL	BHONSLE	Ÿ	JUNE	2016 ©	2016	TITAN	PHARMACEUTICALS	INC.	Ÿ	NASDAQ:TTNP

TITAN PHARMACEUTICALS CORPORATE PRESENTATION Ÿ SUNIL BHONSLE Ÿ JUNE 2016 © 2016 TITAN PHARMACEUTICALS INC. Ÿ NASDAQ:TTNP

Add to Reading List

Source URL: c.eqcdn.com

Language: English - Date: 2016-06-20 16:22:04
2May 10, 2016  Titan Pharmaceuticals Reports First Quarter 2016 Financial Results Titan Management Team to Host Conference Call Today at 4:15 P.M. EDT / 1:15 P.M. PDT

May 10, 2016 Titan Pharmaceuticals Reports First Quarter 2016 Financial Results Titan Management Team to Host Conference Call Today at 4:15 P.M. EDT / 1:15 P.M. PDT

Add to Reading List

Source URL: content.equisolve.net

Language: English - Date: 2016-05-10 07:00:05
3MANAGEMENT TEAM  COMPANY OVERVIEW Marc Rubin, MD

MANAGEMENT TEAM COMPANY OVERVIEW Marc Rubin, MD

Add to Reading List

Source URL: c.eqcdn.com

Language: English - Date: 2016-08-22 18:06:43
4TITAN	PHARMACEUTICALS	  CORPORATE	PRESENTATION	Ÿ	SUNIL	BHONSLE	Ÿ	JUNE	2016 ©	2016	TITAN	PHARMACEUTICALS	INC.	Ÿ	NASDAQ:TTNP

TITAN PHARMACEUTICALS CORPORATE PRESENTATION Ÿ SUNIL BHONSLE Ÿ JUNE 2016 © 2016 TITAN PHARMACEUTICALS INC. Ÿ NASDAQ:TTNP

Add to Reading List

Source URL: c.eqcdn.com

Language: English - Date: 2016-06-20 16:22:04
5Sunil Bhonsle  Apr 2015 Corporate Presentation

Sunil Bhonsle Apr 2015 Corporate Presentation

Add to Reading List

Source URL: c.eqcdn.com

Language: English - Date: 2016-01-28 16:11:59
6C-1  Probuphine for Maintenance Treatment of Opioid Dependence Titan Pharmaceuticals, Inc. FDA Advisory Committee

C-1 Probuphine for Maintenance Treatment of Opioid Dependence Titan Pharmaceuticals, Inc. FDA Advisory Committee

Add to Reading List

Source URL: www.fda.gov

Language: English
7Titan Pharmaceuticals PDAC  March 21, 2013

Titan Pharmaceuticals PDAC March 21, 2013

Add to Reading List

Source URL: www.fda.gov